Status:
COMPLETED
The Pathogenesis of Idiopathic Dry Eyes
Lead Sponsor:
University of Michigan
Conditions:
Dry Eye
Fibromyalgia
Eligibility:
FEMALE
18+ years
Brief Summary
Dry eyes are a very common complaint. In some patients, we can identify the reason for the dryness; however, in others the dryness has no clear cause. Dryness can lead to eye irritation, redness, and ...
Detailed Description
Dry eye and fibromyalgia syndromes are most prevalent in women. Therefore, female patients seen in Kellogg Eye Center for ocular complaints of dryness, grittiness, irritation, or related symptoms, wit...
Eligibility Criteria
Inclusion
- Healthy Controls:
- Female over the age of 18, No symptoms of dry eyes, Must be able to read text on the computer screen and understand English, and not have a physical impairment that prevents you from completing a paper and pencil questionnaire or using a tablet computer
- Fibromyalgia:
- Female over the age of 18, No symptoms of dry eyes, Been diagnosed with fibromyalgia, Must be able to read text on the computer screen and understand English, and not have a physical impairment that prevents you from completing a paper and pencil questionnaire or using a tablet computer
- Dry Eye:
- Female over the age of 18, have symptoms of dry eyes, Must be able to read text on the computer screen and understand English, and not have a physical impairment that prevents you from completing a paper and pencil questionnaire or using a tablet computer
Exclusion
- Pregnant or breast feeding, use of medicated eye drops in last month (Artificial tears ok), diagnosis of autoimmune or rheumatologic disease (e.g. rheumatoid arthritis, crohn's disease, lupus, multiple sclerosis, etc), heart condition requiring daily medications (e.g. angina, congestive heart failure), COPD or asthma requiring daily inhalers (rescue inhalers ok), history of cancer in the past 2 years (skin cancer is ok), use of oral antihistamine medications (e.g. benadryl, claritin, clarinex, zyrtec, allegra, etc), use of oral anticholinergic medications (e.g. scopolamine, ditropan, detrol, ipratropium, etc)
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01254201
Start Date
June 1 2008
End Date
December 1 2015
Last Update
March 15 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan Kellogg Eye Center
Ann Arbor, Michigan, United States, 48105